Windsor, CO, United States of America

Gary Elliot

This inventor holds 1 USPTO granted patent. Top assignee: Dracen Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Elliot. Retrieved from https://idiyas.com/inventor/gary-elliot-z3ttcczd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gary Elliot: Innovator in Pharmaceutical Composition

Introduction

Gary Elliot is a notable inventor based in Windsor, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical use. His work focuses on enhancing the efficacy of drug delivery systems.

Latest Patents

Gary Elliot holds a patent for a lyophilized composition comprising (S)-isopropyl 2-((S)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for subcutaneous administration. This patent outlines the formulation and potential applications of this composition, which is designed for subcutaneous administration to subjects. The patent emphasizes the pharmaceutical compositions, formulations, and their uses in medical treatments.

Career Highlights

Throughout his career, Gary has demonstrated a commitment to advancing pharmaceutical science. His innovative approach has led to the development of unique formulations that aim to improve patient outcomes. He is currently associated with Dracen Pharmaceuticals, Inc., where he continues to contribute to the field.

Collaborations

Gary has worked alongside talented professionals in the industry, including Steven Dykstra and Thomas M Estok. These collaborations have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical research.

Conclusion

In summary, Gary Elliot is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact medical treatments significantly. His dedication to innovation and collaboration continues to drive advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…